Literature DB >> 27207348

A Review of Psoriasis, Therapies, and Suicide.

Melinda Gooderham1, Jennifer Gavino-Velasco2, Cole Clifford2, Alex MacPherson2, Flora Krasnoshtein3, Kim Papp4.   

Abstract

Many chronic medical disorders are associated with psychiatric morbidity. Yet the psychological burden of these disorders often goes unnoticed. In dermatology, psoriasis has a higher association with psychiatric illness, including depression and suicide risk, compared with many other conditions. Studies suggest that effective treatment of psoriasis results in the improvement of psychiatric morbidity, particularly depression and anxiety. New biologic treatments for psoriasis may offer help beyond clearing of the skin in these patients and may lead to a reduction of psychiatric morbidity. Although concerns have been raised regarding the potential link between interleukin-17R blockade in the treatment of psoriasis and suicide, current literature provides no evidence to support this association.
© The Author(s) 2016.

Entities:  

Keywords:  psoriasis; suicide

Mesh:

Substances:

Year:  2016        PMID: 27207348     DOI: 10.1177/1203475416648323

Source DB:  PubMed          Journal:  J Cutan Med Surg        ISSN: 1203-4754            Impact factor:   2.092


  8 in total

Review 1.  The Use of Brodalumab in Three Patients with Psoriasis and Psychiatric Comorbidities.

Authors:  Ryan Rivera-Oyola; Roselyn Stanger; Graham H Litchman; Quinn Thibodeaux; John Koo; Richard Fried; Gary Goldenberg; George Han; Sylvia Hsu; Leon Kircik; Melissa Knuckles; Andrea Murina; Jeffrey Weinberg; Jashin J Wu; Mark Lebwohl
Journal:  J Clin Aesthet Dermatol       Date:  2020-12-01

2.  Long non-coding RNA RP11-342L8.2, derived from RNA sequencing and validated via RT-qPCR, is upregulated and correlates with disease severity in psoriasis patients.

Authors:  Yuanting Zhi; Jiru Du; Miao Qian; Ningjing Song
Journal:  Ir J Med Sci       Date:  2022-01-14       Impact factor: 1.568

3.  Secukinumab Improves Patient Perception of Anxiety and Depression in Patients with Moderate to Severe Psoriasis: A Post hoc Analysis of the SUPREME Study.

Authors:  Marina Talamonti; Giovanna Malara; Ylenia Natalini; Federico Bardazzi; Andrea Conti; Andrea Chiricozzi; Cristina Mugheddu; Paolo Gisondi; Stefano Piaserico; Gianluca Pagnanelli; Paolo Amerio; Concetta Potenza; Franca Cantoresi; Maria Concetta Fargnoli; Anna Balato; Francesco Loconsole; Annamaria Offidani; Claudio Bonifati; Francesca Prignano; Marta Bartezaghi; Alice Rausa; Elisabetta Aloisi; Roberto Orsenigo; Antonio Costanzo
Journal:  Acta Derm Venereol       Date:  2021-03-31       Impact factor: 3.875

4.  Comparative effectiveness of biological therapies on improvements in quality of life in patients with psoriasis.

Authors:  I Y K Iskandar; D M Ashcroft; R B Warren; M Lunt; K McElhone; C H Smith; N J Reynolds; C E M Griffiths
Journal:  Br J Dermatol       Date:  2017-10-19       Impact factor: 9.302

5.  Sex Differences in the Patterns of Systemic Agent use Among Patients With Psoriasis: A Retrospective Cohort Study in Quebec, Canada.

Authors:  Raymond Milan; Jacques LeLorier; Marie-Josée Brouillette; Anne Holbrook; Ivan V Litvinov; Elham Rahme
Journal:  Front Pharmacol       Date:  2022-02-15       Impact factor: 5.810

6.  Trajectories of systemic agent use and associated depression- and anxiety-related health care costs among patients with psoriasis.

Authors:  Raymond Milan; Jacques LeLorier; Eric A Latimer; Marie-Josée Brouillette; Anne Holbrook; Ivan V Litvinov; Elham Rahme
Journal:  JAAD Int       Date:  2022-06-25

7.  Quality of life and patient-perceived symptoms in patients with psoriasis undergoing proactive or reactive management with the fixed-dose combination Cal/BD foam: A post-hoc analysis of PSO-LONG.

Authors:  A Jalili; P Calzavara-Pinton; L Kircik; D Lons-Danic; A Pink; S Tyring; P de la Cueva; M Gooderham; S Segaert; N Nyholm; H Thoning; B Petersen; D Thaçi
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-10-21       Impact factor: 9.228

8.  Asian consensus on assessment and management of mild to moderate plaque psoriasis with topical therapy.

Authors:  Shinichi Imafuku; Min Zheng; Yayoi Tada; Xibao Zhang; Colin Theng; Suganthi Thevarajah; Yi Zhao; Hae Jun Song
Journal:  J Dermatol       Date:  2018-05-09       Impact factor: 4.005

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.